NASDAQ:LKFT Lakefront Biotherapeutics American Depositary Shares Q2 2026 Earnings Results & Report $33.93 +0.59 (+1.77%) As of 04:00 PM Eastern Lakefront Biotherapeutics American Depositary Shares beat analyst expectations on both earnings and revenue in its Q2 2026 results, released August 10, 2026. The company reported EPS of $0.03 versus the -$0.9672 consensus estimate, while revenue of $15.47 million topped the $7.29 million estimate by $8.18 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 10, 2026TimeAfter Market ClosesConference Call DateAugust 11, 2026Conference Call8:00 AM ET Lakefront Biotherapeutics American Depositary Shares EPS ResultsActual EPS$0.03Consensus EPS -$0.9672Beat/MissBeat by +$0.9972One Year Ago EPSN/AEPS Beat Rate6 of last 8 quartersLakefront Biotherapeutics American Depositary Shares Revenue ResultsActual Revenue$15.47 millionExpected Revenue$7.29 millionBeat/MissBeat by +$8.18 millionYoY Revenue GrowthN/AConference Call ResourcesPress ReleaseInterim ReportEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress ReleaseInterim report Lakefront Biotherapeutics American Depositary Shares Q2 2026 Earnings FAQ Did Lakefront Biotherapeutics American Depositary Shares beat earnings estimates for Q2 2026? Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) reported earnings of $0.03 per share for Q2 2026, beating the consensus estimate of -$0.9672. The report was announced on Monday, August 10, 2026. What was Lakefront Biotherapeutics American Depositary Shares' revenue for Q2 2026? Lakefront Biotherapeutics American Depositary Shares reported revenue of $15.47 million for Q2 2026, against a consensus estimate of $7.29 million. Lakefront Biotherapeutics American Depositary Shares Earnings HeadlinesLakefront Swings To Profit In 9-months, Plans Second €50 Mln Share BuybackNovember 12 at 1:52 PM | rttnews.comIs Lakefront Biotherapeutics (ENXTAM:LKFT) Cheap Given Its Earnings Today?November 11 at 10:27 PM | finance.yahoo.comMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.November 12 at 1:00 AM | Weiss Ratings (Ad)Lakefront Biotherapeutics Reports Nine Months 2026 Financial Results and Provides Business UpdateNovember 11 at 4:01 PM | globenewswire.comLakefront to Present at the 2026 Jefferies Global Healthcare Conference in LondonNovember 10 at 4:01 PM | globenewswire.comLakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology MeetingNovember 4, 2026 | globenewswire.comSee More Lakefront Biotherapeutics American Depositary Shares Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Lakefront Biotherapeutics American Depositary Shares? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lakefront Biotherapeutics American Depositary Shares and other key companies, straight to your email. Email Address About Lakefront Biotherapeutics American Depositary SharesLakefront is a clinical-stage biotechnology company developing therapies in immunology and inflammation. Its clinical-stage portfolio includes lead asset gamgertamig, a BCMAxCD3 T-cell engager being developed for the treatment of autoimmune diseases. The company identifies, acquires, and advances therapeutic assets through business development and clinical development activities. Lakefront evaluates opportunities for portfolio expansion based on their scientific, clinical, and commercial potential. Lakefront focuses on developing medicines for diseases with unmet medical needs and advancing its product candidates through clinical development.View Lakefront Biotherapeutics American Depositary Shares ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping3 Pharmaceutical Stocks That Offer Safety and GrowthKeeping AI Cool: AAON Rides the AI Heatwave to Record GrowthPalantir’s Real Washington Risk Isn’t the Budget—It’s OversightCoreWeave's Backlog Is Surging—Can the Stock Follow?Can Constellation Energy's Contracts Power a Stock Rebound? Upcoming Earnings Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
